Glimepiride Treatment Facilitates Ischemic Preconditioning in the Diabetic Heart
نویسندگان
چکیده
منابع مشابه
Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart.
AIMS The diabetic heart is resistant to the myocardial infarct-limiting effects of ischemic preconditioning (IPC). This may be in part due to the downregulation of the phosphatidylinositol 3'-kinase-Akt pathway, an essential component of IPC protection. We hypothesized that treating the diabetic heart with the sulfonylurea, glimepiride, which has been reported to activate Akt, may lower the thr...
متن کاملRemote Ischemic Preconditioning and Diabetic Macular Edema
Objective: Remote Ischemic Preconditioning (RIPC) as the transient ischemia and reperfusion of the arm is a promising method for protecting different tissue from future ischemia. These effects might be mediated through vascular and endothelial growth factor (VEGF) pathway. We investigated the influence of RIPC on diabetic macular edema (DME) as a chronic ischemic condition in patients who were ...
متن کاملToward the heart of ischemic preconditioning.
w x50 Belardinelli L, Linden J, Berne R. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989;32:73–97.w x51 Olafson B, Forman MB, Puett DW. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 1987;76:1135–1145.w x52 Kirsch GE, Codina J, Birnbaumer L, Brown AM....
متن کاملPossible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart
BACKGROUND Nitric oxide (NO) has been noted to produce ischemic preconditioning (IPC)-mediated cardioprotection. Caveolin is a negative regulator of NO, which inhibits endothelial nitric oxide synthase (eNOS) by making caveolin-eNOS complex. The expression of caveolin is increased during diabetes mellitus (DM). The present study was designed to investigate the involvement of caveolin in attenua...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cardiovascular Pharmacology and Therapeutics
سال: 2012
ISSN: 1074-2484,1940-4034
DOI: 10.1177/1074248412468945